Literature DB >> 8117137

Adverse experiences in an Exosurf treated group.

S L Chatfield, E J Kelly, P R Dear.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8117137      PMCID： PMC1060998          DOI： 10.1136/fn.70.1.f78

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  3 in total

1.  Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.

Authors:  R H Phibbs; R A Ballard; J A Clements; D C Heilbron; C S Phibbs; M A Schlueter; S H Sniderman; W H Tooley; A Wakeley
Journal:  Pediatrics       Date:  1991-07       Impact factor: 7.124

2.  Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

Authors:  W Long; T Thompson; H Sundell; R Schumacher; F Volberg; R Guthrie
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

3.  A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.

Authors:  W Long; A Corbet; R Cotton; S Courtney; G McGuiness; D Walter; J Watts; J Smyth; H Bard; V Chernick
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.